Atypical endometrial hyperplasia/EIN and EC shares several molecular alterations with each other, including microsatellite instability, PAX2 inactivation, mutation of PTEN, KRAS, and CTNNB1 (β-catenin), but there is not a linear accumulation of mutational events leading to cancer (31). This evidence concerns the gene KRAS and cancer.